| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, General Counsel
2 companies
Lee Chan Henry serves as a SVP, General Counsel at BEIGF and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 45 sells.
Historically, Lee Chan Henry's trades have earned a below-average insider score of 49/100 across 21 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -25.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | BEIGF Beone Medicines AG | SVP, General Counsel | Sell10b5-1 | 1,115 | $375.00 | $418,125.00 | -100% | - | - | |
| Aug 11, 2026 | BEIGF Beone Medicines AG | SVP, General Counsel | Sale+OE10b5-1 | 2,666 | $360.00 | $959,760.00 | - | - | - | |
| Jul 30, 2026 | BEIGF Beone Medicines AG | SVP, General Counsel | Sell | 1,044 | $323.69 | $337,932.36 | -100% | - | - | |
| Jul 22, 2026 | BEIGF Beone Medicines AG | SVP, General Counsel | Sale+OE10b5-1 | 1,669 | $325.00 | $542,425.00 | - | - | - | |
| Jul 8, 2026 | BEIGF Beone Medicines AG | SVP, General Counsel | Sale+OE10b5-1 | 664 | $302.46 | $200,833.44 | - | - | - | |
| Jun 16, 2026 | ONC Beone Medicines AG | SVP, General Counsel | Sell | 590 | $265.98 | $156,925.25 | -100% | +34.1% | - | |
| Jun 11, 2026 | ONC Beone Medicines AG | SVP, General Counsel | Sell | 428 | $257.64 | $110,267.78 | -100% | +34.9% | - | |
| Jun 8, 2026 | ONC Beone Medicines AG | SVP, General Counsel | Sell | 871 | $270.42 | $235,539.14 | -100% | +29.8% | - | |
| May 13, 2026 | ONC Beone Medicines AG | SVP, General Counsel | Sale+OE10b5-1 | 332 | $310.72 | $103,159.04 | - | +13.5% | - | |
| Apr 8, 2026 | BEIGF Beone Medicines AG | SVP, General Counsel | Sale+OE10b5-1 | 332 | $311.59 | $103,447.88 | - | - | - |